It has been reported that in the murine B-cell lymphoma cell line, the MEK/ERK pathway affects the DNA-binding activity of NF-κB p50/p50 by acting as an upstream signal [20]. The gene discussed is MAPK1; the disease is B-cell non-Hodgkin lymphoma.